Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials.

Marder SR, West B, Lau GS, Pultz JA, Pikalov A, Marcus RN, Gutierrez-Esteinou R, Crandall DT.

J Clin Psychiatry. 2007 May;68(5):662-8.

PMID:
17503974
2.

[Efficacy of aripiprazole for the treatment of schizophrenia: what dose is required?].

Charpeaud T, Samalin L, Llorca PM.

Encephale. 2014 Feb;40(1):62-73. doi: 10.1016/j.encep.2013.12.002. Epub 2014 Jan 18. Review. French.

PMID:
24445245
3.

Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.

Citrome L.

Int J Clin Pract. 2012 Mar;66(3):318-25. doi: 10.1111/j.1742-1241.2011.02890.x. Epub 2012 Jan 9. Review.

PMID:
22226343
4.

Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.

Kane JM, Barnes TR, Correll CU, Sachs G, Buckley P, Eudicone J, McQuade R, Tran QV, Pikalov A 3rd, Assunção-Talbott S.

J Psychopharmacol. 2010 Jul;24(7):1019-29. doi: 10.1177/0269881109348157. Epub 2009 Dec 14. Review.

PMID:
20008446
5.

Aripiprazole in schizophrenia and schizoaffective disorder: A review.

Stip E, Tourjman V.

Clin Ther. 2010;32 Suppl 1:S3-20. doi: 10.1016/j.clinthera.2010.01.021. Review.

PMID:
20152550
6.

Aripiprazole: in adolescents with schizophrenia.

Sanford M, Keating GM.

Paediatr Drugs. 2007;9(6):419-23. Review.

PMID:
18052412
7.

Aripiprazole in pediatric psychosis and bipolar disorder: a clinical review.

Doey T.

J Affect Disord. 2012;138 Suppl:S15-21. doi: 10.1016/j.jad.2012.02.031. Epub 2012 Mar 8. Review.

PMID:
22406333
8.

Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia.

Gonzalez D, Bienroth M, Curtis V, Debenham M, Jones S, Pitsi D, George M.

Curr Med Res Opin. 2013 Mar;29(3):241-50. doi: 10.1185/03007995.2013.766591. Epub 2013 Feb 4.

PMID:
23323879
9.

Aripiprazole for schizophrenia. Systematic review.

El-Sayeh HG, Morganti C, Adams CE.

Br J Psychiatry. 2006 Aug;189:102-8. Review.

10.
11.

A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania.

Dratcu L, Bobmanuel S, Davies W, Farmer A, George M, Rana T, Singh M, Turner M.

Int J Psychiatry Clin Pract. 2012 Oct;16(4):244-58. doi: 10.3109/13651501.2012.709865.

PMID:
22809129
12.

Clinical trials with a new atypical antipsychotic (Aripiprazole): gender specific information analysis.

Montero I, Talavera M, Ruiz I.

Women Health. 2008;47(4):39-51. doi: 10.1080/03630240802100051. Review.

PMID:
18843939
13.

Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment.

Park MH, Han C, Pae CU, Lee SJ, Patkar AA, Masand PS, Fleischhacker WW.

Expert Rev Neurother. 2011 Nov;11(11):1541-52. doi: 10.1586/ern.11.151. Review.

PMID:
22014131
14.

Aripiprazole: in major depressive disorder.

Weber J, Lyseng-Williamson KA, Scott LJ.

CNS Drugs. 2008;22(10):807-13. Review.

PMID:
18788833
15.
16.

Brexpiprazole for the treatment of schizophrenia.

Hsu WY, Lane HY, Lin CH.

Expert Opin Pharmacother. 2017 Feb;18(2):217-223. doi: 10.1080/14656566.2016.1274972. Epub 2017 Jan 16. Review.

PMID:
27997809
17.

Brexpiprazole for the treatment of schizophrenia.

Yee A.

Expert Rev Neurother. 2016;16(2):109-22. doi: 10.1586/14737175.2016.1129901. Epub 2016 Jan 20. Review.

PMID:
26650624
18.

Benzodiazepines in the treatment of schizophrenia: a review and reappraisal.

Wolkowitz OM, Pickar D.

Am J Psychiatry. 1991 Jun;148(6):714-26. Review.

PMID:
1674645
19.

Management of patients presenting with acute psychotic episodes of schizophrenia.

Thomas P, Alptekin K, Gheorghe M, Mauri M, Olivares JM, Riedel M.

CNS Drugs. 2009;23(3):193-212. doi: 10.2165/00023210-200923030-00002. Review.

PMID:
19320529

Supplemental Content

Support Center